Extensive coverage of the major scientific meeting of 2007 from aidsmap.com
To view all news reports published, visit: http://www.aidsmap.com/cms1174967.asp
CROI: Is there a ceiling to CD4 recovery on virologically effective therapy?
Read More >>
CROI: Is tenofovir causing kidney problems?
Read More >>
CROI: Treatment changes and breaks occur at high rate in Ugandan HIV patients
Read More >>
CROI: Remission of Kaposi's sarcoma seen in rural Uganda when HIV treatment given
Read More >>
CROI: High dietary fat and cholesterol contribute to serum lipid levels in people with HIV
Read More >>
CROI: High rate of virologic failure on once-daily combination of 3TC, tenofovir and nevirapine
Read More >>
CROI: Sexually transmitted infections significantly increase risk of drug-resistant HIV transmission
Read More >>
CROI: Use of both cotrimoxazole and insecticide-treated bednets dramatically lowers the risk of malaria in HIV-positive children
Read More >>
CROI: Therapeutic concentrations of efavirenz, Kaletra, could be difficult to achieve in some children, with or without rifampicin
Read More >>
CROI: Large Zambian study finds early abrupt weaning of HIV-exposed infants does not improve HIV-free survival
Read More >>
CROI: Experimental 'salvage' integrase inhibitor, elvitegravir (GS-9137) appears potent at higher doses
Read More >>
CROI: Four African studies suggest health risks associated with abrupt and early weaning of HIV-exposed infants
Read More >>
CROI: Aciclovir therapy for women with HIV and herpes produces modest reductions in genital viral load
Read More >>
CROI: SMART substudy finds people on treatment less likely to transmit HIV, and may take fewer risks
Read More >>
CROI: Smoking increases cancer-associated HPV viral load
Read More >>
CROI: Circumcision could particularly benefit higher-risk men
Read More >>
CROI: HIV testing in New York's bath houses is feasible and reaches men missed by traditional prevention
Read More >>
CROI: New NNRTI, TMC278, demonstrates sustained potency, better CNS and lipid profile than efavirenz, in treatment-naive
Read More >>
CROI: Early weaning and formula feeding puts HIV-exposed infants in resource limited settings at high risk of severe diarrhoea and death
Read More >>
CROI: Rate of CD4 decline is a poor guide to the risk of AIDS, say investigators
Read More >>
CROI: Once daily Kaletra may be less effective when viral load above 100,000 copies/ml
Read More >>
CROI: Recent OIs or AIDS strongest predictors of development of resistance in South African first-line failures
Read More >>
CROI: Haiti is the source of HIV subtype B
Read More >>
CROI: Anti-HBV drug entecavir also active against HIV and promotes antiretroviral resistance
Read More >>
CROI: Further evidence that short-course PMTCT prophylaxis compromises mother's future treatment
Read More >>
CROI: Sexual transmission of HCV not limited to HIV-positive gay men
Read More >>
CROI: Ugandan study confirms low CD4 count, low body weight, TB and anaemia major risk factors for death after starting ART
Read More >>
CROI: Effects of transmitted drug resistance on viral load are drug class specific
Read More >>
CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeks
Read More >>
CROI: Maraviroc shows potent effect in highly treatment-experienced
Read More >>
CROI: Non-AIDS malignancies now more common than AIDS-defining cancers in people with HIV
Read More >>
CROI: HIV treatment should not be delayed in TB patients with low CD4 counts, South African study shows
Read More >>
CROI: Cotrimoxazole prophylaxis reduces risk of death by 41% during first six months of ART
Read More >>
CROI: Microbicide failure poses more questions than answers
Read More >>
CROI: Kaletra less likely to cause fat loss than efavirenz when paired with NRTIs
Read More >>
CROI: Women infected with HIV subtype D progress faster despite same viral load
Read More >>
CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes late
Read More >>
CROI: Alendronate effectively treats bone loss in men and women with HIV
Read More >>
CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophy
Read More >>
CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular disease
Read More >>
CROI: Tenofovir microbicide stops rectal infection in monkeys better than PrEP
Read More >>
CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern Africa
Read More >>
CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy
Read More >>
CROI: Urgent action needed to avert `catastrophic` drug-resistant TB epidemic
Read More >>